These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 23834278
1. Molecular modeling study of dihydrofolate reductase inhibitors. Molecular dynamics simulations, quantum mechanical calculations, and experimental corroboration. Tosso RD, Andujar SA, Gutierrez L, Angelina E, Rodríguez R, Nogueras M, Baldoni H, Suvire FD, Cobo J, Enriz RD. J Chem Inf Model; 2013 Aug 26; 53(8):2018-32. PubMed ID: 23834278 [Abstract] [Full Text] [Related]
2. 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity. Angelina E, Andujar S, Moreno L, Garibotto F, Párraga J, Peruchena N, Cabedo N, Villecco M, Cortes D, Enriz RD. Mol Inform; 2015 Jan 26; 34(1):28-43. PubMed ID: 27490860 [Abstract] [Full Text] [Related]
3. Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations. Rojas S, Parravicini O, Vettorazzi M, Tosso R, Garro A, Gutiérrez L, Andújar S, Enriz R. Eur J Med Chem; 2020 Dec 15; 208():112792. PubMed ID: 32949964 [Abstract] [Full Text] [Related]
8. Enzyme polarization of substrates of dihydrofolate reductase by different theoretical methods. Greatbanks SP, Gready JE, Limaye AC, Rendell AP. Proteins; 1999 Nov 01; 37(2):157-65. PubMed ID: 10584062 [Abstract] [Full Text] [Related]
9. Analysis of Coxiela burnetti dihydrofolate reductase via in silico docking with inhibitors and molecular dynamics simulation. de Souza FR, Guimarães AP, Cuya T, de Freitas MP, Gonçalves ADS, Forgione P, Costa França TC. J Biomol Struct Dyn; 2017 Oct 01; 35(13):2975-2986. PubMed ID: 27726597 [Abstract] [Full Text] [Related]
10. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents. Singh P, Kaur M, Sachdeva S. J Med Chem; 2012 Jul 26; 55(14):6381-90. PubMed ID: 22734697 [Abstract] [Full Text] [Related]
11. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases. da Cunha EF, de Castro Ramalho T, Bicca de Alencastro R, Maia ER. J Biomol Struct Dyn; 2004 Oct 26; 22(2):119-30. PubMed ID: 15317473 [Abstract] [Full Text] [Related]
12. Effect of mutation on enzyme motion in dihydrofolate reductase. Watney JB, Agarwal PK, Hammes-Schiffer S. J Am Chem Soc; 2003 Apr 02; 125(13):3745-50. PubMed ID: 12656604 [Abstract] [Full Text] [Related]
14. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007). Hafner J. J Phys Condens Matter; 2008 Feb 13; 20(6):060301. PubMed ID: 21693862 [Abstract] [Full Text] [Related]